Clinical Trial Update: Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adjuvant chemoradiation with weekly oxaliplatin after resection of head and neck cancer; the study has been terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of California, Irvine | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-05-01